We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
Legal terms for veterinary medicines, marketing of non-medicinal products including medicinal words and phrases, how to complain.
Guidance for the pharmaceutical industry on who can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
If you're advertising or marketing, including direct marketing, you must be accurate and honest and follow the advertising codes of practice
Steps to help grow your business - finding finance, mentors, increasing sales and developing products and services
The seeds which must be certified before you can market them, how to get them certified and how to get a licence for your seed business.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
Guidance on the decentralised and mutual recognition reliance procedure (MRDCRP) for marketing authorisation applications including information on how to apply.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
How the MHRA assesses Marketing Authorisation Applications (MAA) for medicines referred under Article 29.
How the MHRA processes variations to Marketing Authorisations (MAs)
Guidance for the pharmaceutical industry on how to apply to vary a veterinary Marketing Authorisation (MA) or Homeopathic Remedy.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
How to identify and report harmful trade practices that affect your business when exporting, importing or operating domestically.
Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
How an innovative funding mechanism is saving lives by speeding up the availability of vaccines and making them affordable.
How to use a quasi-experimental study to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.